David F Hale is of Dermata Therapeutics, Inc.. Currently has a direct ownership of 75,720 shares of DRMA, which is worth approximately $93,135. The most recent transaction as insider was on Oct 06, 2022, when has been sold 30,155 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 75.7K
0% 3M change
0% 12M change
Total Value Held $93,135

DAVID F HALE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 06 2022
BUY
Grant, award, or other acquisition
-
30,155 Added 28.48%
75,720 Common Stock
Jul 07 2022
BUY
Grant, award, or other acquisition
-
26,441 Added 36.72%
45,565 Common Stock
Apr 07 2022
BUY
Grant, award, or other acquisition
-
15,466 Added 44.71%
19,124 Common Stock

Also insider at

ONCT
Oncternal Therapeutics, Inc. Healthcare
BIOC
BIOCEPT INC Healthcare
DFH

David F Hale

San Diego, CA

Track Institutional and Insider Activities on DRMA

Follow Dermata Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DRMA shares.

Notify only if

Insider Trading

Get notified when an Dermata Therapeutics, Inc. insider buys or sells DRMA shares.

Notify only if

News

Receive news related to Dermata Therapeutics, Inc.

Track Activities on DRMA